A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder. Hereditary ...

Blood clotting disorders can be inherited or acquired and lead to either excessive bleeding or too much clotting.

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug called pomalidomide, which is used to treat bone marrow ...

NBDF’s Advisory Panels give biopharma direct access to patients, caregivers, and clinicians within the bleeding disorders community Pathway to Cures (P2C), the venture philanthropy fund of the ...

A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder. Hereditary ...

Ahmed Khan, 17, was able to undergo a 13-hour brain surgery — despite having a rare blood disorder that complicates clotting ...

Sutacimig Phase 2 interim results demonstrate >50% reduction in treated bleeding event and prophylactic treatment potential in Glanzmann thrombasthenia HMB-002 clinical proof-of-mechanism data in Von ...

Blood clotting depends on speed, force, and timing. Platelets have to stay quiet while circulating through the body, then ...

ST. LOUIS – When it comes to bleeding disorders, most people immediately think of hemophilia. But there’s a wider range of conditions that can affect children, and they often go undetected. Dr. John ...